Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of Alpha Interferon With Long Term Ribavirin Therapy for Chronic Hepatitis C
NCT00001729Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Oct 1997
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ribavirin in hepatitis C (HCV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Oct 1997; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00001729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001729.